Press Release: Magnera Reports First Quarter Results

Dow Jones
Feb 05

CHARLOTTE, N.C., Feb. 04, 2026 (GLOBE NEWSWIRE) --

First Quarter Highlights

   -- GAAP: Net sales of $792 million, Operating income of $14 million 
 
   -- Non-GAAP: Adjusted EBITDA of $93 million 
 
   -- Fiscal 2026 guidance: Reaffirmed adjusted EBITDA of $380 - $410 million 
      and free cash flow of $90 - $110 million 

Curt Begle, Magnera's CEO, commented: "Magnera delivered a strong first quarter that met our expectations and reinforces our full-year 2026 Adjusted EBITDA and free cash flow guidance. These results reflect the continued focus and execution of our teams across the organization.

Capital allocation remains disciplined and aligned with our commitment to debt reduction. During the quarter, we made $27 million in debt payments demonstrating our confidence in our cash flow generation.

Looking ahead, our global teams remain focused on driving long-term shareholder value through decisive actions centered on our strategic pillars of cost optimization, portfolio differentiation, and commercial excellence. We believe these priorities position Magnera well to deliver sustainable performance and continued value creation."

Key Financials

 
                    December Quarter 
GAAP results         2025      2024 
Net sales              $792      $702 
Operating income         14      (22) 
                   --------  -------- 
 
 
 
                             December Quarter   Reported  Comparable(1) 
Adjusted non-GAAP results     2025      2024    <DELTA>%    <DELTA>% 
Net sales                       $792      $702       13%           (7%) 
Adjusted EBITDA(1)                93        84       11%             0% 
                                                          ------------- 
 
 
(1)  (Adjusted non-GAAP results exclude items not considered 
      to be ongoing operations. In addition, comparable 
      change % normalizes the impacts of foreign currency 
      and the recent merger with Glatfelter. Further details 
      related to non-GAAP measures and reconciliations can 
      be found under "Reconciliation of Non-GAAP Financial 
      Measures and Estimates" section or in reconciliation 
      tables in this release. Dollars in millions) 
 
 

Consolidated Overview

The net sales increase of 13% included revenue from the merger of $112 million and favorable foreign currency changes of $36 million that were partially offset by a $52 million decrease in selling prices primarily due to the pass-through of lower raw material costs and a 1% organic volume decline which was attributed to strength in our consumer solutions product categories being more than offset by competitive pressures in South America and general market softness in Europe.

The adjusted EBITDA increase of 11% was primarily due to the contribution from the merger of $8 million.

Americas

The net sales increase in the Americas segment included a 2% organic volume growth, revenue from the merger of $42 million and favorable foreign currency changes of $8 million that were partially offset by a $38 million decrease in selling prices primarily due to the pass-through of lower raw material costs and competitive pressures from imports in South America.

The adjusted EBITDA increase included a contribution from the merger of $5 million and improved organic growth in North America partially offset by unfavorable impacts from price cost spread of $4 million.

Rest of World

The net sales increase in the Rest of World segment included revenue from the merger of $70 million and a $28 million favorable impact from foreign currency changes partially offset by a 5% organic volume decline which was primarily attributed to general market softness in Europe and a $14 million decrease in selling prices primarily due to the pass-through of lower raw material costs.

The adjusted EBITDA increase included a contribution from the merger of $3 million and favorable impacts from price cost spread of $4 million as the result of synergy realization and mix improvement.

Fiscal Year 2026 Guidance -- Reaffirmed

   -- Adjusted EBITDA of $380 - $410 million 
   -- Free cash flow of $90 - $110 million; cash flow from operations of $170 - 
      $190 million 

Investor Conference Call

The Company will host a conference call, February 5, 2026, at 10:00 AM U.S. Eastern Time to discuss the December 2025 quarter results. The webcast can be accessed here. A replay of the webcast will be available via the same link on the Company's website after the completion of the call.

By Telephone

Participants may register for the call here now or any time up to and during the time of the call and will immediately receive the dial-in number and a unique pin to access the call. While you may register at any time up to and during the time of the call, you are encouraged to join the call 15 minutes prior to the start of the event.

About Magnera

Magnera Corporation $(MAGN)$ serves 1,000+ customers worldwide, offering a wide range of material solutions, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. Operating across 45 global facilities, Magnera is supported by approximately 8,500 employees. Magnera's purpose is to better the world with new possibilities made real. For more than 160 years, the Company has delivered the material solutions their partners need to thrive. Through economic upheaval, global pandemics and changing end-user needs, we have consistently found ways to solve problems and exceed expectations. The distinct scale and comprehensive portfolio of products brings customers more materials and choices. Magnera builds personal partnerships that withstand an ever-changing world.

Visit Magnera.com for more information and follow @MagneraCorporation on social platforms.

Non-GAAP Financial Measures and Estimates

This press release includes non-GAAP financial measures including, but not limited to, Adjusted EBITDA, free cash flow, and comparable basis net sales and adjusted EBITDA. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in the United States of America (GAAP) is set forth at the end of this press release. Information reconciling forward-looking adjusted EBITDA and adjusted free cash flow are not provided because such information is not available without unreasonable effort due to high variability, complexity, and low visibility with respect to certain items, including debt refinancing activity or other non-comparable items. These items are uncertain, depend on various factors, and could be material to our results computed in accordance with U.S. GAAP.

Forward Looking Statements

This document contains certain statements that are "forward-looking" statements within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such "forward-looking" statements include, but are not limited to, statements with respect to our future financial performance and condition, results of operations and business, our expectations or beliefs concerning future events, plans, objectives, expectations and intentions, and other statements that are not historical facts. These statements may contain words such as "believes," "expects," "may," "will," "should," "would," "could," "seeks," "approximately," "intends," "plans," "estimates," "projects," "outlook," "guidance," "anticipates" or "looking forward" or similar expressions. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are based upon the current beliefs and expectations of the management of Magnera and are subject to risks and uncertainties that may change at any time. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Although it is not possible to identify all of these risks and uncertainties, they include, among others, the following: global economic conditions; inflation; the cost and availability of raw materials and energy; disruption of our supply chain; the adverse impact of weather events on our facilities, inventory and suppliers, as well as adverse effects on our customers, suppliers and other business partners; the effect of competition on our business; our inability to integrate future acquired companies or to realize expected operating synergies; synergies expected to be achieved in connection with our business combination with a subsidiary of Berry Global Group, Inc.; our inability to retain our officers and employees or the occurrence of labor disputes; disruption of our information technology systems, including as a result of a cyber breach; risks associated with operating internationally, including fluctuating exchange rates, tariffs, differing tax laws and regulation; litigation and regulatory investigations; and disputes related to intellectual property used in our business. Additional information regarding these risks and uncertainties and other risks applicable to our business are described in additional detail in our reports filed with the Securities and Exchange Commission (the "SEC"), including our Annual Report on Form 10-K for the fiscal year ended September 27, 2025, and other filings that we make with the SEC. These risk factors may not contain all of the material factors that are important to you. New factors may emerge from time to time, and it is not possible to either predict new factors or assess the potential effect of any such new factors. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are made as of the date hereof, and we undertake no obligation to publicly update or revise

any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Consolidated and Combined Statements of Operations (unaudited)

 
                                             Quarterly Period Ended 
                                  -------------------------------------------- 
(in millions of dollars)            December 27, 2025      December 28, 2024 
--------------------------------  ---------------------  --------------------- 
 
Net sales                            $         792          $         702 
 
Cost of goods sold                             695                    631 
Selling, general and 
 administrative                                 50                     47 
Amortization of intangibles                     11                     14 
Transaction and other activities                22                     32 
Operating income (loss)                         14                    (22) 
Other expense (income)                           3                     21 
Interest net expense                            40                     26 
--------------------------------  ----  ----------  ---  ----  ----------  --- 
Income (loss) before income 
 taxes                                         (29)                   (69) 
Income tax (benefit) expense                     5                     (9) 
--------------------------------  ----  ----------  ---  ----  ---------- 
Net income (loss)                    $         (34)         $         (60) 
--------------------------------  ----  ----------       ----  ---------- 
 
 

Condensed Consolidated and Combined Statements of Cash Flows (unaudited)

 
                                          Quarterly Period Ended 
                               --------------------------------------------- 
(in millions of dollars)         December 27, 2025       December 28, 2024 
-----------------------------  ----------------------  --------------------- 
      Net cash from (used in) operating 
       activities                               2                     (58) 
 
Cash flows from investing 
activities: 
Additions to property, plant, and 
 equipment, net                               (15)                    (16) 
Cash acquired from GLT acquisition              -                      37 
      Net cash from (used in) investing 
       activities                             (15)                     21 
 
Cash flows from financing 
activities: 
Proceeds from long-term borrowings              -                   1,556 
Repayments on long-term borrowings            (27)                   (430) 
Transfers from (to) Berry, net                  -                      34 
Cash distribution to Berry                      -                  (1,111) 
Debt fees and other, net                        -                     (16) 
----------------------------------------  -------      ------  ---------- 
      Net cash from financing activities      (27)                     33 
Effect of currency translation on cash         (1)                    (11) 
----------------------------------------  -------      ------  ---------- 
Net change in cash and cash equivalents       (41)                    (15) 
Cash and cash equivalents at beginning 
 of period                                    305                     230 
----------------------------------------  -------      ------  ---------- 
Cash and cash equivalents at 
 end of period                   $            264           $         215 
-----------------------------  ---------  -------      ------  ---------- 
 
Non-U.S. GAAP Free Cash Flow: 
Net cash from (used in) operating 
 activities                                     2 
Additions to property, plant, and 
 equipment, net                               (15) 
----------------------------------------  ------- 
Free Cash Flow                                (13) 
----------------------------------------  ------- 
 
 

Condensed Consolidated and Combined Balance Sheets (unaudited)

 
(in millions of dollars)          December 27, 2025     September 27, 2025 
-------------------------------  -------------------  ---------------------- 
Cash and cash equivalents          $             264    $              305 
Accounts receivable                              553                   522 
Inventories                                      476                   474 
Other current assets                              72                   122 
Property, plant, and equipment                 1,453                 1,476 
Goodwill, intangible assets, 
 and other long-term assets                    1,075                 1,090 
-------------------------------  ---  --------------  ---  --------------- 
Total assets                       $           3,893    $            3,989 
-------------------------------  ---  --------------  ---  --------------- 
Current liabilities, excluding 
 current debt                                    556                   601 
Current and long-term debt                     1,931                 1,952 
Other long-term liabilities                      368                   372 
Stockholders' equity                           1,038                 1,064 
-------------------------------  ---  --------------  ---  --------------- 
Total liabilities and 
 stockholders' equity              $           3,893    $            3,989 
-------------------------------  ---  --------------  ---  --------------- 
 
 

Reconciliation of Non-GAAP Measures

(in millions of dollars)

 
Reconciliation of Net sales and Adjusted EBITDA on 
 a supplemental comparable basis by segment 
                   Quarterly Period ended      Quarterly Period ended 
                     December 27, 2025            December 28, 2024 
                           Rest of                     Rest of 
                 Americas   World    Total   Americas   World     Total   LTM 
                 --------  -------  -------  --------  --------  ------- 
Net sales            $440     $352     $792      $420      $282     $702 
Constant FX 
 rates                                              8        28       36 
GLT prior year                                     42        70      112 
Comparable net 
 sales (1)(6)        $440     $352     $792      $470      $380     $850 
 
Operating 
 Income               $10       $4      $14      $(7)     $(15)    $(22)   $41 
Depreciation 
 and 
 amortization          29       20       49        33        20       53   202 
Integration, 
 business 
 consolidation 
 and other 
 activities 
 (2)                   13        6       19        20        12       32    81 
Argentina 
 hyperinflation         3        -        3         -         -        -     7 
GAAP carve-out 
 allocation 
 (3)                    -        -        -         2         1        3     - 
Other non-cash 
 charges (4) 
 (5)                    3        5        8         8        10       18    32 
Adjusted EBITDA 
 (1)                  $58      $35      $93       $56       $28      $84  $363 
                                                                          ---- 
Constant FX 
 rates                                              -         1        - 
GLT prior year                                      5         3        8 
                                    ------- 
Comparable 
 Adjusted 
 EBITDA (1)(6)        $58      $35      $93       $61       $32      $93 
---------------  --------  -------  -------  --------  --------  -------  ---- 
% vs. prior 
 year 
 comparable          (5%)       9%       0% 
Synergies and 
 cost 
 reductions                                                                 60 
                                    ------- 
Comparable 
 Adjusted 
 EBITDA (1)(6)                                                            $423 
 
 

Guidance

 
                                Adjusted     Fiscal 2026     Fiscal 2025 
                Fiscal 2026      EBITDA        Midpoint         Actual 
Cash flow from 
 operating                        Adjusted 
 activities     $170 - $190         EBITDA       $395                 $354 
Additions to                       GLT Pro 
 PPE (net)             (80)          forma                               8 
--------------  ----------- 
                                 Full Year 
                                Comparable 
                                  Adjusted 
Free cash Flow   $90 - $110         EBITDA       $395                 $362 
                               % vs. prior 
                                      year 
                                comparable       9% 
 
 
(1)  Supplemental financial measures that are not required 
      by, or presented in accordance with, accounting principles 
      generally accepted in the United States ("GAAP"). 
      These non-GAAP financial measures should not be considered 
      as alternatives to operating or net income or cash 
      flows from operating activities, in each case determined 
      in accordance with GAAP. Comparable basis measures 
      exclude the impact of currency translation effects 
      and acquisitions. These non-GAAP financial measures 
      may be calculated differently by other companies, 
      including other companies in our industry, limiting 
      their usefulness as comparative measures. Management 
      believes that Adjusted EBITDA and other non-GAAP financial 
      measures are useful to our investors because they 
      allow for a better period-over-period comparison of 
      operating results by removing the impact of items 
      that, in management's view, do not reflect our core 
      operating performance. We define "free cash flow" 
      as cash flow from operating activities less net additions 
      to property, plant, and equipment. We believe free 
      cash flow is useful to an investor in evaluating our 
      liquidity because free cash flow and similar measures 
      are widely used by investors, securities analysts, 
      and other interested parties in our industry to measure 
      a company's liquidity. We believe free cash flow is 
      also useful to an investor in evaluating our liquidity 
      as it can assist in assessing a company's ability 
      to fund its growth through its generation of cash 
      and as pre-merger cash flow is not indicative of our 
      current structure and operations. 
      (We also use Adjusted EBITDA and comparable basis 
      measures, among other measures, to evaluate management 
      performance and in determining performance-based compensation. 
      Adjusted EBITDA is a measure widely used by investors, 
      securities analysts, and other interested parties 
      in our industry to measure a company's performance. 
      We also believe these measures are useful to an investor 
      in evaluating our performance without regard to revenue 
      and expense recognition, which can vary depending 
      upon accounting methods.) 
(2)  (Includes restructuring, business optimization and 
      other charges, which includes $17 million of transaction 
      compensation expense in the prior year) 
(3)  (Consists of estimated parent-allocated charges for 
      the period prior to merger which is required by GAAP 
      as part of the carve-out financial statement process) 
(4)  (Prior year includes $12 million inventory step-up 
      charge related to the merger and other non-cash charges) 
(5)  (Includes stock compensation expense and equipment 
      disposals) 
(6)  (The prior year comparable basis change excludes the 
      impacts of foreign currency and acquisition/mergers) 
 
 

IR Contact Information

Robert Weilminster

EVP, Investor Relations

IR@magnera.com

(END) Dow Jones Newswires

February 04, 2026 16:36 ET (21:36 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10